Among them, there may be previously listed Fos, Junb, Jak2, Npas4, Egr2 and other proteins, which may help to validate some key signaling pathways after peptide treatment at the protein level and reveal the potential effects of peptides on ischemic stroke. This evidence concerns the gene JAK2 and ischemic stroke.